Regis Duval

Regis Duval serves as the Chief Commercial Officer at Nagi Bioscience, leading the introduction of innovative “Organism-on-Chip” technology for substance testing. Prior to this role, Regis contributed to various organizations, including O+GROUP and Molecular Plasma Group, and held significant positions at 10x Genomics as Vice President and General Manager for EMEA, where Regis expanded team size and implemented business processes for growth. At Thermo Fisher Scientific, Regis was Vice President of Global Commercial Operations in Microbiology, achieving top-line growth and enhancing customer engagement. As Chief Executive Officer of Immunodiagnostic Systems, Regis oversaw the development of diagnostic assays. Previous roles include senior leadership positions at Bio-Rad Laboratories, GE Healthcare Life Sciences, and BD, showcasing expertise in sales operations, marketing, and organizational restructuring. Regis holds an MBA in Strategic Finance from the University of Westminster and additional qualifications in public speaking and marketing.